Home
Continued Medical Education
Cancer A – Z
Leukemia
Editorial Advisory Board
Join Our Editorial Advisory Board
Contact Us
Terms and Conditions
Publications
ADC Review | J. Antibody-drug Conjugates
Resources for For Clinicians
Drug Map (ADC)
Peer Review Articles
The Review
Physician’s Weekly
Oncology Hematology (General)
Chemotherapy
Colon Cancer
Hematology
Leukemia
Lung Cancer
Lymphoma
Myleoma
Ovarian Cancer
Prostate Cancer
Renal Cell Carcinoma
Changing Strategies in the War on Cancer
Changing Strategies in the War on Cancer – Episode 1
Changing Strategies in the War on Cancer – Episode 2
Changing Strategies in the War on Cancer – Episode 3
Journal of CAR T-Cell Therapy
About CAR T-cells
Frequently Asked Questions
Types of Articles
Submit a Manuscript
The Onco’Zine Brief
The Onco’Zine Brief Episodes
The Onco’Zine Brief on PRX
The Onco’Zine Brief on Spreaker
UK Health Radio
Upcoming Programs | Shows
How to Support The Onco’Zine Brief
Corporate Underwriting and Sponsorship
Programs | Shows
The Onco’Zine Dossier
Thalidomide: A History
Thalidomide: In the Shadow of Death
Controversy: The involvement of Ciba AG in the development of Thalidomide
Thalidomide’s Secret Past: The Link with Nazi Germany
Reversal of Fortune: How a Vilified Drug Became a Life-saving Agent in the ‘War’ Against Cancer
Smoking and Health
New Surgeon General’s Report Presents the Unfiltered Truth About Tobacco
Smoking and the Lost Legacy of the First Surgeon General’s Report on Smoking and Health
Tobacco Control in the United States Has Saved 8 Million Lives In Last 50 Years
Tobacco Companies are Finally Moving Closer to Revealing the Truth about Smoking
The Harmful Effects of Smoking: The Public Denial in the Early-mid 1960s
Drug Approvals 2017 – 2020
Oncology & Hematology – FDA Drug Approvals 2018
Oncology & Hematology – FDA Drug Approvals 2019
Oncology & Hematology – FDA Drug Approvals 2020
Articles
Latest Articles
Expert Interviews
Editorials and Commentaries
Eric Rosenthal Reports
Publications
News
Business & Economics
Clinical Development
Conference Coverage
COVID19 – Cancelled Medical Meetings 2020
Oncology Directory
Join Today
Event Agenda
Video
Careers
Search
About
Advertise
Advisory Board
Contact Us
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Password recovery
Recover your password
your email
A password will be e-mailed to you.
Onco'Zine
Advertisement #1
Home
Continued Medical Education
Cancer A – Z
Leukemia
Editorial Advisory Board
Join Our Editorial Advisory Board
Contact Us
Terms and Conditions
Publications
ADC Review | J. Antibody-drug Conjugates
Resources for For Clinicians
Drug Map (ADC)
Peer Review Articles
The Review
Physician’s Weekly
Oncology Hematology (General)
Chemotherapy
Colon Cancer
Hematology
Leukemia
Lung Cancer
Lymphoma
Myleoma
Ovarian Cancer
Prostate Cancer
Renal Cell Carcinoma
Changing Strategies in the War on Cancer
Changing Strategies in the War on Cancer – Episode 1
Changing Strategies in the War on Cancer – Episode 2
Changing Strategies in the War on Cancer – Episode 3
Journal of CAR T-Cell Therapy
About CAR T-cells
Frequently Asked Questions
Types of Articles
Submit a Manuscript
The Onco’Zine Brief
The Onco’Zine Brief Episodes
The Onco’Zine Brief on PRX
The Onco’Zine Brief on Spreaker
UK Health Radio
Upcoming Programs | Shows
How to Support The Onco’Zine Brief
Corporate Underwriting and Sponsorship
Programs | Shows
The Onco’Zine Dossier
Thalidomide: A History
Thalidomide: In the Shadow of Death
Controversy: The involvement of Ciba AG in the development of Thalidomide
Thalidomide’s Secret Past: The Link with Nazi Germany
Reversal of Fortune: How a Vilified Drug Became a Life-saving Agent in the ‘War’ Against Cancer
Smoking and Health
New Surgeon General’s Report Presents the Unfiltered Truth About Tobacco
Smoking and the Lost Legacy of the First Surgeon General’s Report on Smoking and Health
Tobacco Control in the United States Has Saved 8 Million Lives In Last 50 Years
Tobacco Companies are Finally Moving Closer to Revealing the Truth about Smoking
The Harmful Effects of Smoking: The Public Denial in the Early-mid 1960s
Drug Approvals 2017 – 2020
Oncology & Hematology – FDA Drug Approvals 2018
Oncology & Hematology – FDA Drug Approvals 2019
Oncology & Hematology – FDA Drug Approvals 2020
Articles
Latest Articles
Expert Interviews
Editorials and Commentaries
Eric Rosenthal Reports
Publications
News
Business & Economics
Clinical Development
Conference Coverage
COVID19 – Cancelled Medical Meetings 2020
Oncology Directory
Join Today
Event Agenda
Video
Careers
Home
Featured
Page 3
Featured
Featured articles
The History, Reality and Promise of Immunotherapy for Cancer
Daniel A. Vorobiof, MD
-
February 25, 2021
Remembering Emil “Jay” Freireich—the Man Who Made Vince DeVita a ‘Believer’
Theranostics Technology: A New Approach to Cancer Diagnosis and Treatment
Easing the Burden of Cancer Beyond Medicine through the Astellas Oncology C3 Prize
Precision Technology Transforms the Way Leading Hospitals Diagnose and Treat Prostate Cancer
How a Hollywood-and-Scientist Dream Team Created a New Paradigm in Collaborative...
Eric T. Rosenthal
-
September 22, 2018
Opioid Prescribing and Cancer Pain ? Contemporary Challenges
Larry Driver
-
September 3, 2018
?Stronger by Sharing? Founder Wins Pinnacle Book Achievement Award for 2018...
Peter Hofland, Ph.D
-
September 2, 2018
Stronger by Sharing: 5 Reasons Why It’s Important to Share Your...
Manon Rinsma
-
August 21, 2018
Why Do We Need a Right-to-Try Bill in America?
Jane Orient
-
June 12, 2018
Artificial Intelligence Better than Dermatologists in Diagnosing Skin Cancer
Peter Hofland, Ph.D
-
May 29, 2018
Personalized Medicine: Vaccine Triggers a Broad Response in Mobilizing
Sonia Portillo
-
April 14, 2018
1
2
3
Page 3 of 3
LATEST NEWS
AmunBio and NorthShore University to Advance Cancer Immunotherapy with Engineered Oncolytic Viruses
Peter Hofland, Ph.D
-
April 13, 2021
A Spaceship on Mars and Screening for Gynecologic Cancer
Valena Wrtight, MD
-
April 6, 2021
Are Cytology and Imaging Adequate for the Diagnostic Management of Brain Metastasis?
Michael C. Dugan, M.D.
-
April 1, 2021
Combination of SLC-391 + Pembrolizumab Enters Clinical Trial Advanced NSCLC
Peter Hofland, Ph.D
-
March 31, 2021
Revealing the Blind Spot in Cancer Treatment with Host Response Profiling
Ofer Sharon, MD, MBA
-
March 22, 2021